Time interval of measles vaccination in patients with Kawasaki disease treated with additional intravenous immune globulin

Miura, Masaru; Katada, Yoshiaki; Ishihara, Jun

doi:10.1007/s00431-003-1335-3

Cited by 20 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Whereas an interval of 6-11 months is recommended in Japan and the USA, there is no agreement with regard to the nonresponders who had received a second IVIG pulse. Miura et al [39 ] suggest 9 months to be the optimal time interval for measles vaccination and possibly for mumps, rubella, and varicella viruses in re-treated children. The gap may be reduced if there is a risk of virus exposure, since passive immunization is not fully protective.…”

Section: Vaccinationsmentioning

confidence: 98%

Kawasaki disease

Falcini

2006

Current Opinion in Rheumatology

View full text Add to dashboard Cite

Due to earlier recognition, aggressive medical treatment, and surgical procedures, the quality of life in patients with Kawasaki disease is significantly improved. The identification of children at high risk for coronary artery aneurysms is crucial in order to reduce the occurrence of sudden death in adolescence and early adulthood. High parameters of inflammation, anemia, and low sodium and albumin levels, along with persistent unexplained fever, should alert clinicians to suspect the disease even though all clinical symptoms are lacking.

show abstract

Section: Vaccinationsmentioning

confidence: 98%

Kawasaki disease

Falcini

2006

Current Opinion in Rheumatology

View full text Add to dashboard Cite

show abstract

“…Current Australian recommendations are to delay MMR for 3 months and varicella vaccine for 9 months 105 . The US practice of delaying MMR for 11 months post IVIG 106 suggests that further research is warranted 107 . Other childhood immunizations should not be delayed.…”

Section: Immunizations Following Intravenous Immunoglobulinmentioning

confidence: 99%

The diagnosis and management of Kawasaki disease

Royle

Burgner

Curtis

2005

J Paediatrics Child Health

View full text Add to dashboard Cite

Kawasaki disease (KD) is a systemic vasculitis of childhood with a predilection for the coronary arteries. It is the predominant cause of paediatric acquired heart disease in developed countries. The aetiology of KD remains unknown and consequently there is no diagnostic test. The diagnosis is made using a constellation of clinical criteria that in isolation have poor sensitivity and specificity. Early treatment prevents overt coronary artery damage in the majority of children. The long-term effects of childhood KD on later cardiovascular health remain unknown. A recent study showed that treatment of KD in Australia is suboptimal, with late diagnosis occurring in approximately half of the cases and an unacceptably high incidence of acute cardiac involvement. These guidelines highlight the difficulties in the diagnosis of KD and offer some clues that may assist early recognition of this important paediatric disease. They also detail current treatment recommendations and the evidence on which they are based. Increased awareness of the epidemiology and spectrum of the clinical presentation of KD is essential for early recognition and optimal management.

show abstract

“…Live vaccines-including measles, mumps, and rubella-should be delayed after treatment with intravenous immunoglobulin, because neutralising antibodies may decrease vaccine immunogenicity. 20 …”

Section: Other Interventionsmentioning

confidence: 99%